Drugs@FDA application record, NDA 008085 (METHOTREXATE SODIUM tablets) (1953)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · December 7, 1953

U.S. Food et al., 1953-12-07: FDA application record for oral methotrexate sodium showing an original approval dated 7 December 1953 and Strides Pharma International as current holder.

12/07/1953

HTML record, unpaginated

U.S. Food et al., 1953-12-07: FDA application record for oral methotrexate sodium showing an original approval dated 7 December 1953 and Strides Pharma International as current holder. Funder/conflicts: n/a. Maker: current holder Strides Pharma International; 1953 sponsor (Lederle Laboratories) is not named on the FDA page. Comparator: n/a. A separate injectable NDA (011719, Hospira) also exists. No composition-of-matter patent for methotrexate was located for this run (see Run Notes). Study type: regulatory record.